/Hyperphosphatemia in patients with chronic kidney disease

Hyperphosphatemia in patients with chronic kidney disease

author:admin       pubdate:2017-08-11 17:24

Hyperphosphatemia in patients with chronic kidney disease

Hyperphosphatemia in patients with chronic kidney disease

When the serious damage of kidney function, the phosphorus content in the blood will rise, not only will cause a series of complications can cause myocardial infarction, angina and stroke and other serious life-threatening diseases.

Experts, in patients with chronic kidney disease must improve on hyperphosphatemia attention. There are three treatment strategies in clinic at present, including the control of food intake in phosphorus, an increase in the number of dialysis or prolong the duration of dialysis, and the use of phosphate binders. Non calcium phosphate binder non metals, due to the influence of serum calcium and parathyroid hormone no, it can delay the vascular calcification, by the guidelines of hyperphosphatemia and continued for vascular calcification in patients with chronic kidney disease, is the best choice for chronic kidney disease especially in dialysis patients, the incidence of cardiovascular calcification is high and serious. China cardiovascular calcification in dialysis patients the prevalence rate of up to 77.4%.

Suggested that the application of active vitamin D3 and calcium supplement the blood phosphorus decline, how specific applications need to actively cooperate with medical treatment.

 

Tag:
  • hyperphosphatemia    
  • Realated article